As of January 22, 2025, Savara Pharmaceuticals (SVRA) has a market cap of $0.48 billion USD. According to our data, Savara Pharmaceuticals is ranked No.6181 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.48 B |
-9.77%
|
Dec 31, 2024 | $0.53 B |
-34.68%
|
Dec 29, 2023 | $0.81 B |
203.23%
|
Dec 30, 2022 | $0.27 B |
25.00%
|
Dec 31, 2021 | $0.21 B |
7.83%
|
Dec 31, 2020 | $0.20 B |
-74.33%
|
Dec 31, 2019 | $0.77 B |
-40.82%
|
Dec 31, 2018 | $1.30 B |
-48.99%
|
Dec 29, 2017 | $2.55 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Insmed
INSM
|
$14.03 B |
0.000 M
|
USA
|
Vertex Pharmaceuticals
VRTX
|
$110.22 B |
0.001 M
|
USA
|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
BioMarin Pharmaceutical
BMRN
|
$11.82 B |
0.000 M
|
USA
|
Sarepta Therapeutics
SRPT
|
$11.09 B |
0.000 M
|
USA
|
Alnylam Pharmaceuticals
ALNY
|
$34.38 B |
-0.000 M
|
USA
|
Ionis Pharmaceuticals
IONS
|
$5.13 B |
-0.000 M
|
USA
|
Ultragenyx
RARE
|
$3.97 B |
0.000 M
|
USA
|
PTC Therapeutics
PTCT
|
$3.48 B |
-0.000 M
|
USA
|
Blueprint Medicines
BPMC
|
$7.06 B |
-0.000 M
|
USA
|
Market Cap | = | SVRA Stock Price | * | SVRA Shares Outstanding |
= | $2.77 | * | 0.17 B | |
= | $0.48 B |